Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Albert Do MD, MPH

Albert Do MD, MPH

Assistant Professor of Medicine, Section of Digestive Diseases, Department of Internal Medicine; Clinical Director, Yale Fatty Liver Disease Program, Yale University School of Medicine, New Haven, Connecticut

Dr. Do received his Bachelor’s Degrees in Molecular and Cell Biology and Psychology at the University of California at Berkeley and a medical doctorate and Master’s in Public Health at Boston University. He completed his residency and fellowship training at Yale University, concurrently obtaining board certification in obesity medicine.

He is the Clinical Director of the Yale University Fatty Liver Disease Program, and has expertise and interest in hepatology, obesity medicine, gastroenterology, and general internal medicine. He is particularly interested in all forms of fatty liver disease, including nonalcoholic fatty liver disease and associated obesity, as well as alcohol-associated fatty liver disease, which are significant clinical and public health problems. He also is interested in clinical research, in particular the development of observational cohorts and epidemiological research with large databases. Dr. Do has been recognized with several awards including the American Association for the Study of Liver Diseases (AASLD) Emerging Liver Scholar Award, the American Gastroenterological Association (AGA) Young Investigator Award, and the Yale School of Medicine Samuel Kushlan Award for Excellence in research.


Dr. Do has no relevant disclosures.